Smallpox vaccination: Risk considerations for patients with atopic dermatitis Renata J.M. Engler, MDa, Julie Kenner, MD, PhDb, Donald Y.M. Leung, MD, PhDc Journal of Allergy and Clinical Immunology Volume 110, Issue 3, Pages 357-365 (September 2002) DOI: 10.1067/mai.2002.128052 Copyright © 2002 Mosby, Inc. Terms and Conditions
Fig. 1 Eczema vaccinatum. (Photographs furnished by John M. Leedom, MD. Additional smallpox images are available at www.bt.cdc.gov/Agent/Smallpox/Smallpox.asp .) Journal of Allergy and Clinical Immunology 2002 110, 357-365DOI: (10.1067/mai.2002.128052) Copyright © 2002 Mosby, Inc. Terms and Conditions
Fig. 2 Eczema vaccinatum resulting from contact with recently vaccinated child. This patient recovered without sequelae or permanent ocular damage. (Photographs furnished by John M. Leedom, MD. Additional smallpox images are available at www.bt.cdc.gov/Agent/Smallpox/Smallpox.asp .) Journal of Allergy and Clinical Immunology 2002 110, 357-365DOI: (10.1067/mai.2002.128052) Copyright © 2002 Mosby, Inc. Terms and Conditions
Fig. 3 Protective immune responses against smallpox virus. Journal of Allergy and Clinical Immunology 2002 110, 357-365DOI: (10.1067/mai.2002.128052) Copyright © 2002 Mosby, Inc. Terms and Conditions